Medline Paste
NDC Package 53329-156-83

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Medline (menthol, white petrolatum, zinc oxide) pastes is clotrimazole and Betamethasone Dipropionate Cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum in patients 17 years and older. This formulation utilizes a paste delivery system. Marketed by Medline Industries, Lp, this product is identified by NDC 53329-156 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
53329-156-83
Package Description
4 g in 1 PACKET
Product Code
53329-156
11-Digit Billing Format
53329015683
RxNorm Crosswalk
  • RxCUI: 2642278 - menthol 0.44 % / petrolatum 53 % / zinc oxide 20.6 % Topical Paste
  • RxCUI: 2642278 - menthol 0.0044 MG/MG / petrolatum 0.53 MG/MG / zinc oxide 0.206 MG/MG Paste
  • RxCUI: 2642278 - menthol 0.0044 MG/MG / petrolatum 0.53 MG/MG / ZNO 0.206 MG/MG Paste
  • RxCUI: 308714 - clotrimazole 1 % / betamethasone 0.05 % Topical Cream
  • RxCUI: 308714 - betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Cream

Clinical Specifications

Proprietary Name
Medline
Non-Proprietary Name
Menthol, White Petrolatum, Zinc Oxide
Substance Name
Menthol; Petrolatum; Zinc Oxide
Dosage Form
Paste - A semisolid3 dosage form, containing a large proportion (20 – 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Clotrimazole and Betamethasone Dipropionate Cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum in patients 17 years and older.

Regulatory & Marketing

Labeler Name
Medline Industries, Lp
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-01-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (53329-156). Click a package code to view its specific billing and regulatory data.

53329-156-14
57 g in 1 TUBE
53329-156-44
113 g in 1 TUBE
53329-156-96
144 PACKET in 1 BOX / 4 g in 1 PACKET (53329-156-83)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53329-156-83 identifies a specific commercial package of 4 g in 1 packet of Medline, a human over the counter drug labeled by Medline Industries, Lp. This paste is formulated for topical use and contains menthol; petrolatum; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medline Industries, Lp on April 01, 2023. The current certification is valid through December 31, 2026.

How is this Medline Industries, Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53329015683. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53329-156-83
11-Digit CMS (5-4-2)
53329-0156-83

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.